Okay, let's tackle this question about the oncogene associated with Burkitt's lymphoma. First, I need to recall what I know about Burkitt's lymphoma. It's a type of non-Hodgkin lymphoma, right? And I remember that certain cancers are associated with specific genetic mutations or oncogenes. The question is asking which oncogene is linked here.

Wait, oncogenes are genes that have the potential to cause cancer when mutated. So the key here is to think about the genetic translocations or mutations that are characteristic of Burkitt's lymphoma. I think Burkitt's is known for a specific chromosomal translocation involving the c-myc gene. Let me confirm that.

The c-myc gene is located on chromosome 8. In Burkitt's lymphoma, there's a translocation between chromosome 8 and another chromosome, typically 14, 2, or 22. The most common one is t(8;14)(q24;q32), which moves the c-myc gene next to the immunoglobulin heavy chain gene on chromosome 14. This translocation leads to the overexpression of c-myc, which drives the rapid proliferation of B-cells, contributing to the aggressive nature of Burkitt's lymphoma.

So the oncogene in question here is c-myc. Now, let's consider the answer options. The correct answer would be the option that lists c-myc. The other options might include other oncogenes like BCL-2, which is associated with follicular lymphoma and t(14;18) translocation. Or maybe BCR-ABL for chronic myeloid leukemia, or HER2 in breast cancer. So the incorrect options would be other oncogenes from different cancers.

To make sure, I should also think about other translocations. For example, t(15;17) is for APL (acute promyelocytic leukemia) involving PML-RARA. And t(11;14) is for mantle cell lymphoma with cyclin D1. So none of these are related to Burkitt's. Therefore, the correct oncogene is definitely c-myc.

The clinical pearl here is that Burkitt's lymphoma is strongly associated with the c-myc translocation, and this is a key diagnostic marker. Students should remember the translocation partners and the specific oncogene involved. Also, the presence of the c-myc overexpression leads to a very aggressive cancer, which is why prompt treatment is crucial in these cases.

**Core Concept**
Burkitt's lymphoma is a highly aggressive B-cell lymphoma characterized by a chromosomal translocation that dysregulates the **c-myc** oncogene. This translocation, typically **t(8;14)**, juxtaposes the c-myc gene on chromosome 8 with the immunoglobulin heavy chain (IgH) locus on chromosome 14, leading to constitutive c-myc overexpression and uncontrolled cell proliferation.

**Why the Correct Answer is Right**
The **c-myc** oncogene is central to Burkitt's lymphoma pathogenesis. Its translocation to the IgH locus results in deregulated transcription, causing B-cells to proliferate rapidly without undergoing apoptosis. This genetic abnormality is present in ~90% of sporadic cases

✓ Correct Answer: C. C-MYC